Multiplexed functional assessments of MYH7 variants in human cardiomyocytes at scale
暂无分享,去创建一个
L. Starita | D. Fowler | W. Chien | C. Murry | A. Stempien-Otero | Clayton E. Friedman | Shawn Fayer | S. Farris | Erica C. Jonlin | Sriram Pendyala | Alexander M. Loiben | Linda Tran | Leslie Chao | Ashley Mckinstry | Kai-Chun Yang | Dania Ahmed | Erica C Jonlin | Leslie S Chao
[1] David T. Miller,et al. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). , 2023, Genetics in medicine : official journal of the American College of Medical Genetics.
[2] N. Sniadecki,et al. Cardiomyocyte Apoptosis Is Associated with Contractile Dysfunction in Stem Cell Model of MYH7 E848G Hypertrophic Cardiomyopathy , 2023, International journal of molecular sciences.
[3] L. Starita,et al. CRaTER enrichment for on-target gene-editing enables generation of variant libraries in hiPSCs , 2023, bioRxiv.
[4] M. Claussnitzer,et al. Scalable Functional Assays for the Interpretation of Human Genetic Variation. , 2022, Annual review of genetics.
[5] Beau R. Webber,et al. Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy , 2022, bioRxiv.
[6] C. Marboe,et al. Muscle LIM Protein Force-Sensing Mediates Sarcomeric Biomechanical Signaling in Human Familial Hypertrophic Cardiomyopathy , 2022, Circulation.
[7] Alan F. Rubin,et al. Closing the gap: Systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA1, TP53, and PTEN. , 2021, American journal of human genetics.
[8] Aidan N. Gomez,et al. Disease variant prediction with deep generative models of evolutionary data , 2021, Nature.
[9] W. Chung,et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG) , 2021, Genetics in Medicine.
[10] Matthew W. Martinez,et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Circulation.
[11] J. Spudich,et al. Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state , 2020, Proceedings of the National Academy of Sciences.
[12] Yu-Sheng Chen,et al. Development of a Cardiac Sarcomere Functional Genomics Platform to Enable Scalable Interrogation of Human TNNT2 Variants , 2020, Circulation.
[13] E. Ashley,et al. Silencing of MYH7 ameliorates disease phenotypes in human iPSC-Cardiomyocytes. , 2020, Physiological genomics.
[14] C. Denning,et al. Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics , 2020, Journal of molecular and cellular cardiology.
[15] J. F. Staples,et al. Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy , 2020, Circulation.
[16] C. Mummery,et al. Inherited cardiac diseases, pluripotent stem cells, and genome editing combined—the past, present, and future , 2019, Stem cells.
[17] K. Musunuru,et al. Functional Annotation of TNNT2 Variants of Uncertain Significance With Genome-Edited Cardiomyocytes. , 2018, Circulation.
[18] Deok‐Ho Kim,et al. Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells , 2018, JACC. Basic to translational science.
[19] Z. Bar-Joseph,et al. Single-Cell Transcriptomic Analysis of Cardiac Differentiation from Human PSCs Reveals HOPX-Dependent Cardiomyocyte Maturation. , 2018, Cell stem cell.
[20] Chris Denning,et al. CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy , 2018, European heart journal.
[21] Vanessa E. Gray,et al. Multiplex Assessment of Protein Variant Abundance by Massively Parallel Sequencing , 2018, Nature Genetics.
[22] Birgit Funke,et al. Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel , 2018, Genetics in Medicine.
[23] B. Hadland,et al. Generating high-purity cardiac and endothelial derivatives from patterned mesoderm using human pluripotent stem cells , 2016, Nature Protocols.
[24] D. MacArthur,et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples , 2016, Genetics in Medicine.
[25] Ricardo Villamarín-Salomón,et al. ClinVar: public archive of interpretations of clinically relevant variants , 2015, Nucleic Acids Res..
[26] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[27] Matthew S. Lebo,et al. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity , 2015, Genetics in Medicine.
[28] Bin Zhang,et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations , 2014, Nucleic Acids Res..
[29] M. Peckham,et al. Structural Implications of β‐Cardiac Myosin Heavy Chain Mutations in Human Disease , 2014, Anatomical record.
[30] Jiajie Zhang,et al. PEAR: a fast and accurate Illumina Paired-End reAd mergeR , 2013, Bioinform..
[31] Gordon Keller,et al. Differentiation of Embryonic Stem Cells to Clinically Relevant Populations: Lessons from Embryonic Development , 2008, Cell.
[32] J. Moult,et al. Loss of protein structure stability as a major causative factor in monogenic disease. , 2005, Journal of molecular biology.
[33] Claudine Attias-Donfut,et al. Analyses , 1994, Gérontologie et société.
[34] N. Dokholyan,et al. Protein Destabilization as a Common Factor in Diverse Inherited Disorders , 2015, Journal of Molecular Evolution.
[35] I. Schlichting,et al. Crystal structures of human cardiac beta-myosin II S2-Delta provide insight into the functional role of the S2 subfragment. , 2006, Proceedings of the National Academy of Sciences of the United States of America.